Skip to content

Quick ratio at other companies

Rogers Corporation logo
Rogers CorporationROG
+0.2×
Vera Therapeutics logo
Vera TherapeuticsVERA
13.6×-14.0×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
2.5×+0.5×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
1.9×-0.4×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
13.6×-4.3×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
3.3×-0.1×

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's quick ratio?
Aurinia Pharmaceuticals (AUPH) reported quick ratio of 5× in Q1 2026.
How has Aurinia Pharmaceuticals's quick ratio changed year-over-year?
Aurinia Pharmaceuticals's quick ratio decreased by 4.6% year-over-year, from 5.3× to 5×.
What is the long-term trend for Aurinia Pharmaceuticals's quick ratio?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's quick ratio has grown at a -17.8% compound annual growth rate (CAGR), from 12.7× to 4.8×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.